high throughput screening core

July 14, 2020

New tools to study bioactive lipids

Vanderbilt researchers have identified and characterized inhibitors of an enzyme that synthesizes lipid signaling molecules with roles in energy balance, inflammation and addiction.

By Leigh MacMillan

June 12, 2020

Robotic technology speeds arrhythmia gene classification

Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions.

By Leigh MacMillan

February 9, 2016

Therapies to prevent preterm birth

Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.

By Leigh MacMillan

January 22, 2015

VUMC research cores speed pace of discovery

Progress against America’s most intractable health challenges, among them heart disease, cancer and diabetes, requires the best minds, the latest tools and the easy collaboration demanded by 21st century science.

By Bill Snyder

November 26, 2014

New tools to probe manganese biology

Vanderbilt researchers have developed tools to probe the role of the essential metal manganese in neurons, and which offer a started point for developing therapeutic agents for manganese-related neurological disorders.

By Leigh MacMillan

March 19, 2014

Small molecule protects kidney filter

A compound identified at Vanderbilt has therapeutic potential in protecting the kidney filter barrier.

By Bill Snyder

February 11, 2013

VU, GlaxoSmithKline team to develop novel treatments for severe obesity

Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.